| Předmět: |
|
| Zdroj: |
Hematology Week; 12/22/2023, p424-424, 1p |
| Abstrakt: |
A recent study conducted at Loma Linda University Medical Center in California explored the potential of zinc supplementation as a treatment for anemia in patients with myelodysplastic syndrome (MDS). The researchers found that zinc supplementation led to an improvement in hemoglobin levels over a 12-month period. The study suggests that zinc may play a role in erythropoiesis, the production of red blood cells, and could be a cost-effective and well-tolerated treatment option for MDS patients. Further research is needed to understand the specific mechanisms and potential toxicity of zinc supplementation in MDS. [Extracted from the article] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
